Haijun Tian is a Real World Evidence (RWE) and Health Economics & Outcomes Research (HE&OR) professional currently serving as Associate Vice President of Real World Evidence Strategy at Eli Lilly and Company. From 2015 to 2020, they held various leadership roles at Novartis, including Director of RWE and Data Science in Global Medical Affairs. They also worked as a Senior Statistician at IQVIA from 2006 to 2010. Haijun earned a Ph.D. in Health Policy Analysis from The Pardee RAND Graduate School and holds two degrees in Public Administration from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices